http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017042828-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ea08e4fc0c0fefe840241b46496ef50
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
filingDate 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa12360416acdebd1c26f6b44c34e8df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6290f20d9edf5a9e389ff089a9617acb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c9da6c2cef19de032b6f6c3fc522f9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18c6731fae7e6bfdac54a85bee342a8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93f58fd773724869b6ecc07574e82b86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5af60f35dd83b723fad3918edf79db95
publicationDate 2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017042828-A3
titleOfInvention Process for the preparation of selexipag
abstract The present invention provides processes for the preparation of Selexipag compound of formula (1). The present invention also provides processes for the preparation of 4-[(5,6-diphenyl-pyrazin-2-yl)-isopropyl -amino]-butan-1-ol (2), and 4-isopropylamino-butan-1-ol of formula (3), which are intermediates for the synthesis of Selexipag (1 ).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109651164-B
priorityDate 2015-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1400518-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012101276-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226478952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12950986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18452655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228268411

Total number of triples: 29.